The Economist on Global Fake and Substandard Pharmaceuticals

The Economist discusses the growing global problem of fake and substandard pharmaceuticals in Fake pharmaceuticals: Bad medicine — The world’s drug supply is global.  Governments have failed to keep up.  Absent from The Economist‘s discussion of government regulators and industry self-policing is the role of private litigation.  Couldn’t emerging global tort litigation also deter wrongdoers and be part of the solution?

BGS